Following positive recommendations from an expert advisory panel the previous day, Japan on 21 May granted formal emergency approval to two more COVID-19 vaccines, from Moderna, Inc./Takeda Pharmaceutical Co. Ltd. and AstraZeneca PLC/University of Oxford.
New Options For Japan As More COVID-19 Vaccines Finally Approved
Nods For Moderna, AstraZeneca
Japan has granted emergency approvals to two more vaccines for COVID-19, both from multinational developers, as it finally expands a so far very limited armory against the pandemic.
